EN
FR
Export
export
Export
PDF
Excel (XLSX)
Word (DOCX)
You can select particular sections to be included in the output file.
Select all
Select classic EML layout
Indication
ICD-11
ATC codes
List type
Formulations
Therapeutic alternatives
Footnote
INN
Medicine type
Antibiotic groups
Sex
Age
Age restriction
Weight restriction
Patent information
Expert Committee decision justification
Cancel
Download
EN
FR
Model List of Essential Medicines
clear
Found 8 recommendations for 6 medicines and 4 therapeutic equivalents
Removed medicines and rejected applications are not shown.
Show them
.
29.3. Medicines for juvenile joint diseases
Acetylsalicylic acid
General information
Section
Medicines for juvenile joint diseases
Oral > Solid: 100 to 500 mg
Local > Rectal > Suppository: 50 to 150 mg
Indications
Acute rheumatic fever without mention of heart involvement
Mucocutaneous lymph node syndrome
Juvenile idiopathic arthritis
Adalimumab
General information
Section
Medicines for juvenile joint diseases
Parenteral > General injections > SC: 40 mg per 0.8 mL; 40 mg per 0.4 mL; 10 mg per 0.2 mL; 20 mg per 0.4 mL
Indications
Juvenile idiopathic arthritis
Certolizumab pegol
General information
Section
Medicines for juvenile joint diseases
Indications
Therapeutic equivalent to
adalimumab
for
Juvenile idiopathic arthritis
Etanercept
General information
Section
Medicines for juvenile joint diseases
Indications
Therapeutic equivalent to
adalimumab
for
Juvenile idiopathic arthritis
Golimumab
General information
Section
Medicines for juvenile joint diseases
Indications
Therapeutic equivalent to
adalimumab
for
Juvenile idiopathic arthritis
Infliximab
General information
Section
Medicines for juvenile joint diseases
Indications
Therapeutic equivalent to
adalimumab
for
Juvenile idiopathic arthritis
Methotrexate
General information
Section
Medicines for juvenile joint diseases
Oral > Solid > tablet: 2.5 mg (as sodium salt)
Indications
Juvenile idiopathic arthritis
Triamcinolone hexacetonide
General information
Section
Medicines for juvenile joint diseases
Parenteral > Locoregional injections > Intra-articular: 20 mg per mL in vial
Indications
Juvenile idiopathic arthritis